USP17L9P

Across TCGA pan-cancer cohorts, USP17L9P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated USP17L9P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher USP17L9P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated USP17L9P expression acts as an unfavorable survival marker.

ESCA are the cancer types where USP17L9P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	II,III,IV	0.248	0.686	.019	27	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

USP17L9P–ESCA (OS)

Open the ESCA breakdown →